Economic burden of atherotrombotic disease in the Czech Republic
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation | |
| Description | A total number of 49,215 patients suffering from both CAD and PAD was estimated. In lifetime horizon, these patients will develop 18,766 myocardial infarctions, 7,439 strokes, 6,639 cases of extracranial and 1,525 intracranial haemorrhage, 5,311 cases of acute limb ischaemia, 4,648 amputations, 3,098 cases of venous thromboembolism and 22,292 cardiovascular deaths. From a healthcare payer perspective, all these events will be associated with a total cost of €360.7 million. According to CSSA database, CAD or PAD induce 1,946 cases of invalidity per year, corresponding to €7.4 million of invalidity pensions annually and €24.7 million loss of productivity/year. Moreover, CAD or PAD lead to 4,802 sick-leaves each year, corresponding to annual productivity loss of €55.5 million. In sum, these indirect costs equal to €87.6 million per year. |